The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy
Clinical trial NCT01842581 · COMPLETED
Trial details
- NCT number
- NCT01842581
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-08
- Primary completion
- 2014-12-17
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.